{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:15:37Z","timestamp":1790784937887,"version":"4.1.0"},"reference-count":22,"publisher":"Japanese Society of Internal Medicine","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2014]]},"DOI":"10.2169\/internalmedicine.53.2250","type":"journal-article","created":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T13:43:21Z","timestamp":1404222201000},"page":"1429-1433","source":"Crossref","is-referenced-by-count":12,"title":["Overlap of IgG4-related Sclerosing Cholangitis and Primary Biliary Cirrhosis"],"prefix":"10.2169","volume":"53","author":[{"given":"Reika","family":"Takemoto","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Mitoyo General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Miyake","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Harada","sequence":"additional","affiliation":[{"name":"Department of Human Pathology, Kanazawa University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuni","family":"Nakanuma","sequence":"additional","affiliation":[{"name":"Department of Human Pathology, Kanazawa University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Moriya","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Mitoyo General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaharu","family":"Ando","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Mitoyo General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamoru","family":"Hirohata","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Mitoyo General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhide","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med 366: 539-551, 2012.","DOI":"10.1056\/NEJMra1104650"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Okazaki K, Uchida K, Ikeura T, Takaoka M. Current concept and diagnosis of IgG4-related disease in the hepato-bilio-pancreatic system. J Gastroenterol 48: 303-314, 2013.","DOI":"10.1007\/s00535-012-0744-3"},{"key":"3","unstructured":"3. Ghazale A, Chari ST, Zhang L, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology 134: 706-715, 2008."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ; American Association for Study of Liver Diseases. Primary biliary cirrhosis. Hepatology 50: 291-308, 2009.","DOI":"10.1002\/hep.22906"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Honda A, Ikegami T, Nakamuta M, et al. Anticholestatic effects of bezafibrate in patients with primary biliary cirrhosis treated with ursodeoxycholic acid. Hepatology 57: 1931-1941, 2013.","DOI":"10.1002\/hep.26018"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Naitoh I, Nakazawa T, Hayashi K, et al. A case of IgG4-related sclerosing cholangitis overlapped with primary biliary cirrhosis. Intern Med 51: 1695-1699, 2013.","DOI":"10.2169\/internalmedicine.51.7327"},{"key":"7","unstructured":"7. Wiegand J, Neid M, Kaiser T, et al. Coexistence of autoimmune pancreatitis and primary biliary cirrhosis in a Caucasian patient: a rare cause of cholestasis. Z Gastroenterol 44: 1227-1229, 2006."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ohara H, Okazaki K, Tsubouchi H, et al. Research Committee of IgG4-related Diseases; Research Committee of Intractable Diseases of Liver and Biliary Tract; Ministry of Health, Labor and Welfare, Japan; Japan Biliary Association. Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012. J Hepatobiliary Pancreat Sci 19: 536-542, 2012.","DOI":"10.1007\/s00534-012-0521-y"},{"key":"9","unstructured":"9. Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31: 929-938, 1999."},{"key":"10","unstructured":"10. Berg PA, Klein R, Lindenborn-Fotinos J, Klöppel W. ATPase-associated antigen (M2): marker antigen for serological diagnosis of primary biliary cirrhosis. Lancet 2: 1423-1426, 1982."},{"key":"11","unstructured":"11. Ohara H, Nakazawa T, Kawa S, et al. Establishment of a serum IgG4 cut-off value for the differential diagnosis of IgG4-related sclerosing cholangitis: a Japanese cohort. J Gastroenterol Hepatol 28: 1247-1251, 2013."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Umemura T, Zen Y, Hamano H, et al. Clinical significance of immunoglobulin G4-associated autoimmune hepatitis. J Gastroenterol 46 (Suppl 1): 48-55, 2011.","DOI":"10.1007\/s00535-010-0323-4"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Nakazawa T, Naitoh I, Hayashi K, Miyabe K, Simizu S, Joh T. Diagnosis of IgG4-related sclerosing cholangitis. World J Gastroenterol 19: 7661-7670, 2013.","DOI":"10.3748\/wjg.v19.i43.7661"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Nishimori I, Morita M, Kino J, et al. Pancreatic involvement in patients with Sjögren's syndrome and primary biliary cirrhosis. Int J Pancreatol 17: 47-54, 1995.","DOI":"10.1007\/BF02788358"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Fausa O, Kolmannskog F, Ritland S. The pancreatic ducts in primary biliary cirrhosis and sclerosing cholangitis. Scand J Gastroenterol Suppl 107: 32-35, 1985.","DOI":"10.3109\/00365528509099749"},{"key":"16","unstructured":"16. Tang KH, Schofield JB, Powell-Jackson PR. Primary biliary cirrhosis and idiopathic retroperitoneal fibrosis: a rare association. Eur J Gastroenterol Hepatol 14: 783-786, 2002."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Shikuwa S, Omagari K, Mizuta Y, et al. Primary biliary cirrhosis associated with idiopathic retroperitoneal fibrosis. J Gastroenterol 35: 646-648, 2000.","DOI":"10.1007\/s005350070067"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Sevenet F, Capron-Chivrac D, Delcenserie R, Lelarge C, Delamarre J, Capron JP. Idiopathic retroperitoneal fibrosis and primary biliary cirrhosis. A new association? Arch Intern Med 145: 2124-2125, 1985.","DOI":"10.1001\/archinte.1985.00360110200042"},{"key":"19","unstructured":"19. Harada K, Hirohara J, Ueno Y, et al. Incidence of and risk factors for hepatocellular carcinoma in primary biliary cirrhosis: national data from Japan. Hepatology 57: 1942-1949, 2013."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Bogdanos DP, Baum H, Grasso A, et al. Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis. J Hepatol 40: 31-39, 2004.","DOI":"10.1016\/S0168-8278(03)00501-4"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Shimoda S, Harada K, Niiro H, et al. Interaction between Toll-like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis. Hepatology 53: 1270-1281, 2011.","DOI":"10.1002\/hep.24194"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Watanabe T, Yamashita K, Fujikawa S, et al. Involvement of activation of toll-like receptors and nucleotide-binding oligomerization domain-like receptors in enhanced IgG4 responses in autoimmune pancreatitis. Arthritis Rheum 64: 914-924, 2012.","DOI":"10.1002\/art.33386"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/13\/53_53.2250\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,10]],"date-time":"2022-04-10T05:28:46Z","timestamp":1649568526000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/13\/53_53.2250\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":22,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.53.2250","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}